Appropriate prescribing in elderly people: how well can it be measured and optimised?
By A. Spinewine, K. Schmader, N. Barber, C. Hughes, K. Lapane, C. Swine, J. Hanlon. The Lancet, 2007
944 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Economics and Econometrics, Geriatrics and Gerontology
View Paper: https://www.semanticscholar.org/paper/5eea8bff76f8887809c6be78a14b2b358daad24c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Fortin
- C. Boyd
- S. Holt
- S. Schmiedl
- P. Thürmann
Citations in the corpus
- Future of Multimorbidity Research: How Should Understanding of Multimorbidity Inform Health System Design? (2010, background): “For both of these examples, evidence-based interventions have been shown to improve patient important outcomes, and yet, neither is considered a “disease”.(82,83) Throughout healthcare, the disease-based focus prevails, from the design of clinical trials to the reimbursement structure in many countr”
- Potentially inappropriate medications in the elderly: the PRISCUS list. (2010, methodology): “40 42283 Wuppertal, Germany E-Mail: petra.thuermann@helios-kliniken.de Conflict of interest statement In the past five years, Professor Thürmann has received honoraria for conducting two clinical phase I studies (on behalf of STADA AG and Biotest Pharma AG).”